文献速递白血病造血干细胞移植与细胞治疗

白血病驱动的3型固有淋巴细胞扩增促进急性髓系白血病促肿瘤微环境

Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemia.
PubMed 文献 · Leukemia · 2025-12-22

该研究在AML小鼠模型和患者中发现3型固有淋巴细胞(ILC3)扩增,其由白血病母细胞分泌的AHR配体激活前体细胞AHR介导;ILC3通过分泌TNFα和GM-CSF增强AML集落形成,共转移ILC3加速疾病进展,且人ILC3频率与不良风险分层相关。

要点

  • AML中ILC3扩增,由AHR激活ILC前体介导
  • ILC3来源的TNFα和GM-CSF促进AML集落形成
  • 人ILC3频率与AML不良风险分层相关

核心结论

  • AML通过AHR依赖机制促进ILC3扩增和功能增强,进而支持AML生长和存活。
  • ILC3频率与AML患者不良风险分层相关,提示其作为促肿瘤微环境组分的作用。

研究设计与样本

  • 研究采用AML小鼠模型和AML患者样本,结合建模研究与体外共培养实验。
  • 通过共转移ILC3与AML细胞进行体内疾病进展分析。

主要发现

  • 在AML小鼠模型和AML患者中均观察到ILC3扩增。
  • 建模研究显示ILC3扩增由ILC前体中的AHR激活介导。
  • 白血病环境中发育的ILC3细胞因子产生增加。
  • ILC3共培养通过ILC3来源的TNFα和GM-CSF显著增加AML集落形成。
  • ILC3与AML共转移导致体内疾病进展更迅速,且人ILC3频率与AML不良风险分层相关。

临床怎么用

  • ILC3频率可能作为AML风险分层的辅助指标。
  • 靶向AHR-ILC3轴或ILC3来源的TNFα/GM-CSF可能成为AML治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with poor overall survival. Understanding how dysregulated immunity contributes to the development and progression of AML is an active area of investigation. Prior work has demonstrated functional defects in natural killer (NK) cells; however, the role of non-NK innate lymphoid cells (ILCs) in AML is incompletely understood. Conventional ILC3s are non-cytotoxic and regulate mucosal immunity through cytokine secretion. In this study, we discovered an expansion of ILC3s in both a murine model of AML and in AML patients. The transcription factor, aryl hydrocarbon receptor (AHR) is required for ILC3 development and function, and AML blasts have been shown to secrete AHR ligands. Modeling studies demonstrated ILC3 expansion was mediated by AHR activation in ILC precursors. ILC3s developed in leukemic settings had increased cytokine production, and co-culture of ILC3s significantly increased AML colony formation, which was mediated by ILC3-derived TNFα and GM-CSF. Furthermore, co-transfer of ILC3s with AML led to more rapid disease progression in vivo and human ILC3 frequency was associated with adverse risk stratification in AML patients. These data support a model in which AML promotes ILC3 expansion and function via an AHR-dependent mechanism to aid AML growth and survival.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Dinh TTT, Lordo MR, Zhang AY, et al. Leukemia-driven expansion of type 3 innate lymphoid cell facilitates a pro-tumoral microenvironment in acute myeloid leukemia. Leukemia. 2025. PMID: 41430399. doi:10.1038/s41375-025-02829-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。